The global burden of headache

D Saylor, TJ Steiner - Seminars in neurology, 2018 - thieme-connect.com
At the turn of the century, most of the world's population lived in regions where the
prevalence of headache was unknown and its impact poorly understood. Lifting The Burden …

Clinical bacteriology in low-resource settings: today's solutions

S Ombelet, JB Ronat, T Walsh, CP Yansouni… - The Lancet Infectious …, 2018 - thelancet.com
Low-resource settings are disproportionately burdened by infectious diseases and
antimicrobial resistance. Good quality clinical bacteriology through a well functioning …

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase …

A Leuzy, NJ Ashton, N Mattsson-Carlgren… - European journal of …, 2021 - Springer
Purpose In the last decade, the research community has focused on defining reliable
biomarkers for the early detection of Alzheimer's disease (AD) pathology. In 2017, the …

Cryptococcal antigen in serum and cerebrospinal fluid for detecting cryptococcal meningitis in adults living with human immunodeficiency virus: systematic review and …

E Temfack, JJB Rim, R Spijker, A Loyse… - Clinical Infectious …, 2021 - academic.oup.com
Cryptococcal antigen (CrAg) detection could direct the timely initiation of antifungal therapy.
We searched MEDLINE and Embase for studies where CrAg detection in …

Global HIV neurology: a comprehensive review

KT Thakur, A Boubour, D Saylor, M Das, DR Bearden… - Aids, 2019 - journals.lww.com
Neurological conditions associated with HIV remain major contributors to morbidity and
mortality and are increasingly recognized in the aging population on long-standing …

High cryptococcal antigen titers in blood are predictive of subclinical cryptococcal meningitis among human immunodeficiency virus-infected patients

RM Wake, E Britz, C Sriruttan, I Rukasha… - Clinical infectious …, 2018 - academic.oup.com
Background High mortality rates among asymptomatic cryptococcal antigen (CrAg)–positive
patients identified through CrAg screening, despite preemptive fluconazole treatment, may …

Advanced HIV: diagnosis, treatment, and prevention

S Prabhu, JI Harwell, N Kumarasamy - The lancet HIV, 2019 - thelancet.com
Substantial progress has been made this century in bringing millions of people living with
HIV into care, but progress for early HIV diagnosis has stalled. Individuals first diagnosed …

Inadequacy of high-dose fluconazole monotherapy among cerebrospinal fluid cryptococcal antigen (CrAg)–positive human immunodeficiency virus-infected persons …

T Beyene, AG Zewde, A Balcha, B Hirpo… - Clinical Infectious …, 2017 - academic.oup.com
A total of 817 human immunodeficiency virus-infected Ethiopians with CD4< 150 cells/mL
underwent plasma cryptococcal antigen (CRAG) screening. CRAG prevalence was 6.2%. Of …

Advanced human immunodeficiency virus disease in Botswana following successful antiretroviral therapy rollout: incidence of and temporal trends in cryptococcal …

MW Tenforde, M Mokomane, T Leeme… - Clinical infectious …, 2017 - academic.oup.com
Background Botswana has a well-developed antiretroviral therapy (ART) program that
serves as a regional model. With wide ART availability, the burden of advanced human …

[HTML][HTML] Barriers to headache care in low-and middle-income countries

D Mortel, N Kawatu, TJ Steiner, D Saylor - Eneurologicalsci, 2022 - Elsevier
Headache disorders are a common cause of disability globally and lead not only to physical
disability but also to financial strain, higher rates of mental health disorders such as …